Logo image of FNA

PARAGON 28 INC (FNA) Stock Fundamental Analysis

NYSE:FNA - New York Stock Exchange, Inc. - US69913P1057 - Common Stock - Currency: USD

13  -0.01 (-0.08%)

After market: 13 0 (0%)

Fundamental Rating

3

Taking everything into account, FNA scores 3 out of 10 in our fundamental rating. FNA was compared to 191 industry peers in the Health Care Equipment & Supplies industry. While FNA seems to be doing ok healthwise, there are quite some concerns on its profitability. FNA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year FNA has reported negative net income.
In the past year FNA has reported a negative cash flow from operations.
In multiple years FNA reported negative net income over the last 5 years.
In multiple years FNA reported negative operating cash flow during the last 5 years.
FNA Yearly Net Income VS EBIT VS OCF VS FCFFNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -20M -40M -60M -80M

1.2 Ratios

Looking at the Return On Assets, with a value of -20.89%, FNA is in line with its industry, outperforming 52.63% of the companies in the same industry.
Looking at the Return On Equity, with a value of -45.24%, FNA is in line with its industry, outperforming 51.58% of the companies in the same industry.
Industry RankSector Rank
ROA -20.89%
ROE -45.24%
ROIC N/A
ROA(3y)-15.46%
ROA(5y)-7.89%
ROE(3y)-27.27%
ROE(5y)-13.33%
ROIC(3y)N/A
ROIC(5y)N/A
FNA Yearly ROA, ROE, ROICFNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 10 -10 -20 -30 -40

1.3 Margins

Looking at the Gross Margin, with a value of 75.22%, FNA belongs to the top of the industry, outperforming 86.84% of the companies in the same industry.
In the last couple of years the Gross Margin of FNA has remained more or less at the same level.
FNA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 75.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.05%
GM growth 5YN/A
FNA Yearly Profit, Operating, Gross MarginsFNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 -20 40 60 80

More info and screens

4

2. Health

2.1 Basic Checks

FNA does not have a ROIC to compare to the WACC, probably because it is not profitable.
FNA has more shares outstanding than it did 1 year ago.
FNA has a worse debt/assets ratio than last year.
FNA Yearly Shares OutstandingFNA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 20M 40M 60M 80M
FNA Yearly Total Debt VS Total AssetsFNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

An Altman-Z score of 4.06 indicates that FNA is not in any danger for bankruptcy at the moment.
FNA's Altman-Z score of 4.06 is fine compared to the rest of the industry. FNA outperforms 72.63% of its industry peers.
A Debt/Equity ratio of 0.79 indicates that FNA is somewhat dependend on debt financing.
FNA's Debt to Equity ratio of 0.79 is on the low side compared to the rest of the industry. FNA is outperformed by 73.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF N/A
Altman-Z 4.06
ROIC/WACCN/A
WACC8.87%
FNA Yearly LT Debt VS Equity VS FCFFNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 50M -50M 100M 150M

2.3 Liquidity

FNA has a Current Ratio of 3.50. This indicates that FNA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.50, FNA is in the better half of the industry, outperforming 64.21% of the companies in the same industry.
A Quick Ratio of 1.60 indicates that FNA should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.60, FNA perfoms like the industry average, outperforming 43.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.5
Quick Ratio 1.6
FNA Yearly Current Assets VS Current LiabilitesFNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for FNA have decreased strongly by -48.98% in the last year.
Looking at the last year, FNA shows a quite strong growth in Revenue. The Revenue has grown by 18.16% in the last year.
The Revenue has been growing by 24.92% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-48.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)18.16%
Revenue growth 3Y24.92%
Revenue growth 5YN/A
Sales Q2Q%18.1%

3.2 Future

FNA is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.10% yearly.
The Revenue is expected to grow by 18.51% on average over the next years. This is quite good.
EPS Next Y-13.97%
EPS Next 2Y8.26%
EPS Next 3Y12.39%
EPS Next 5Y6.1%
Revenue Next Year17.57%
Revenue Next 2Y16.01%
Revenue Next 3Y15.28%
Revenue Next 5Y18.51%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
FNA Yearly Revenue VS EstimatesFNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
FNA Yearly EPS VS EstimatesFNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -0.2 -0.4 -0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for FNA. In the last year negative earnings were reported.
Also next year FNA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FNA Price Earnings VS Forward Price EarningsFNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FNA Per share dataFNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

FNA's earnings are expected to grow with 12.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.26%
EPS Next 3Y12.39%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for FNA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PARAGON 28 INC

NYSE:FNA (2/4/2025, 8:04:01 PM)

After market: 13 0 (0%)

13

-0.01 (-0.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)02-27 2025-02-27/amc
Inst Owners59.86%
Inst Owner Change-0.12%
Ins Owners15.07%
Ins Owner Change2.21%
Market Cap1.09B
Analysts85.45
Price Target14.62 (12.46%)
Short Float %7.48%
Short Ratio3.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.77%
Min EPS beat(2)0.01%
Max EPS beat(2)5.52%
EPS beat(4)2
Avg EPS beat(4)-47.2%
Min EPS beat(4)-150.24%
Max EPS beat(4)5.52%
EPS beat(8)3
Avg EPS beat(8)-33.28%
EPS beat(12)4
Avg EPS beat(12)-38.7%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.22%
Min Revenue beat(2)0.57%
Max Revenue beat(2)1.87%
Revenue beat(4)3
Avg Revenue beat(4)0.75%
Min Revenue beat(4)-0.83%
Max Revenue beat(4)1.87%
Revenue beat(8)7
Avg Revenue beat(8)1.01%
Revenue beat(12)11
Avg Revenue beat(12)2.92%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.46%
EPS NQ rev (1m)1.28%
EPS NQ rev (3m)-38.89%
EPS NY rev (1m)1.28%
EPS NY rev (3m)2.55%
Revenue NQ rev (1m)0.73%
Revenue NQ rev (3m)-2.14%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)1.05%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.44
P/FCF N/A
P/OCF N/A
P/B 7.81
P/tB 11.7
EV/EBITDA N/A
EPS(TTM)-0.73
EYN/A
EPS(NY)-0.47
Fwd EYN/A
FCF(TTM)-0.71
FCFYN/A
OCF(TTM)-0.48
OCFYN/A
SpS2.93
BVpS1.67
TBVpS1.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.89%
ROE -45.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 75.22%
FCFM N/A
ROA(3y)-15.46%
ROA(5y)-7.89%
ROE(3y)-27.27%
ROE(5y)-13.33%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.05%
GM growth 5YN/A
F-Score4
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 103.73%
Cap/Sales 7.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.5
Quick Ratio 1.6
Altman-Z 4.06
F-Score4
WACC8.87%
ROIC/WACCN/A
Cap/Depr(3y)243.93%
Cap/Depr(5y)266.2%
Cap/Sales(3y)17.05%
Cap/Sales(5y)15.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-48.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
EPS Next Y-13.97%
EPS Next 2Y8.26%
EPS Next 3Y12.39%
EPS Next 5Y6.1%
Revenue 1Y (TTM)18.16%
Revenue growth 3Y24.92%
Revenue growth 5YN/A
Sales Q2Q%18.1%
Revenue Next Year17.57%
Revenue Next 2Y16.01%
Revenue Next 3Y15.28%
Revenue Next 5Y18.51%
EBIT growth 1Y-29.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year70.58%
EBIT Next 3Y38.46%
EBIT Next 5Y26.29%
FCF growth 1Y28.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.71%
OCF growth 3YN/A
OCF growth 5YN/A